{"id":"W4402560830","doi":"10.1016/j.annonc.2024.08.917","title":"855P Safety and efficacy of vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in previously untreated advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II KEYVIBE-005 study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care South East; Northeast Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; TIGIT; Head and neck; Head and neck cancer; Oncology; Immunotherapy; Cancer research; Internal medicine; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006891835,0.0003931292,0.0008748915,0.0002404064,0.0002483759,0.0008800208,0.0004090101,0.0006005075,0.001783047],"category_scores_gemma":[0.0005236901,0.0002403851,0.0007223399,0.0002581516,0.0003894503,0.0005548074,0.0002402307,0.001268796,0.0006828695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009039333,"about_ca_system_score_gemma":0.0005318084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001300066,"about_ca_topic_score_gemma":0.002144493,"domain_scores_codex":[0.9996929,0.000111511,0.00001286819,0.00005709718,0.00005150651,0.00007415679],"domain_scores_gemma":[0.999832,0.00003384806,0.00003645718,0.00001611474,0.00001391606,0.0000675703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3900033,0.01763858,0.02999174,0.001239666,0.003446767,0.0004551316,0.0003341312,0.005738985,0.1357063,0.0007541336,0.007897466,0.4067938],"study_design_scores_gemma":[0.2240621,0.5184451,0.1853126,0.0002473591,0.00414972,0.001274322,0.0003068062,0.006245618,0.03734877,0.0007062962,0.02180593,0.00009546227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939716,0.003513981,0.0001607968,0.0001907467,0.00007094427,0.0001182146,0.0003854818,0.00004213985,0.001546123],"genre_scores_gemma":[0.9966314,0.001003864,0.000198722,0.0002580252,0.00004534765,0.00008276875,0.0008082759,0.00001172032,0.0009597447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001783047,"threshold_uncertainty_score":0.006558537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03000376623706928,"score_gpt":0.3450944541369353,"score_spread":0.315090687899866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}